Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy

AIDS

Volumn 14, Issue 16, 2000, Pages 2615-2617

  Martínez, Esteban ^a   García Viejo, Miguel A ^a   Marcos, Maria A ^a   Pérez Cuevas, José B ^a   Blanco, José L ^a   Mallolas, Josep ^a   Miró, José M ^a   Gatell, José M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; FLUCONAZOLE;

ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID EXAMINATION; CYTOMEGALOVIRUS; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SECONDARY PREVENTION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; CHEMOPREVENTION; FEMALE; FLUCONAZOLE; HIV INFECTIONS; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED;

EID: 0033730439     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200011100-00029     Document Type: Article

References (6)

1. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection
2. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
3. Practice guidelines for the management of cryptococcal disease
4. Discontinuation of antifungal therapy for cryptococcosis after immunologic response to antiretroviral therapy
5. Serum cryptococcal antigen in patients with AIDS
6. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: Value in the management of AIDS-associated cryptococcal meningitis